CAS 1373422-53-7 appears in our catalog under these names: GSK J1, GSK J1, GSK-J1/ 99.67% (existing batch purity), GSK-J1, GSK-J1 99%. Offered by: TRC, GLPBio, TargetMol, Biosynth, Chemat. Available pack sizes: 100mg, 10mg, 25mg, 10mM (in 1ml dmso), 50mg, 5mg, 1mg, 250mg.
GSK-J1 is a monocarboxylic acid, a member of pyridines, a benzazepine, an aminopyrimidine, a secondary amino compound and a tertiary amino compound. It has a role as an EC 1.14.11.68 ([histone H3]-trimethyl-L-lysine(27) demethylase) inhibitor and an antineoplastic agent.
Source: ChEBI
| Molecular formula | C22H23N5O2 |
|---|---|
| Molecular weight | 389.4 g/mol |
| IUPAC name | 3-[[2-pyridin-2-yl-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino]propanoic acid |
| InChIKey | AVZCPICCWKMZDT-UHFFFAOYSA-N |
| SMILES | C1CN(CCC2=CC=CC=C21)C3=NC(=NC(=C3)NCCC(=O)O)C4=CC=CC=N4 |
Computed by PubChem (NCBI)